“NDELA” Nitrosamine in pharma products

Pharmaceutical companies, involved in the production of finished pharmaceutical products, such as topical creams or foams, following the risk assessment envisaged by EMA guidelines, must investigate the presence of any traces of N-Nitrosodiethanolamine (NDELA) in their finished products.

Learn more

Latest update: 21/09/2021 11:29:18

In the same section